Key result
Type 2 endoleak developed in 39% of patients after EVAR and did not significantly increase long-term mortality, though 31 of 85 affected patients required secondary intervention for sac growth.
Why the study?
Type 2 endoleak is associated with aneurysm enlargement and secondary interventions, but definitive consensus on its management remains lacking.
Does the development of type 2 endoleak after EVAR increase mortality or the need for secondary interventions in patients with abdominal aortic aneurysms?
Observational (n=216)
No
Does the development of type 2 endoleak after EVAR increase mortality or the need for secondary interventions in patients with abdominal aortic aneurysms?
Type 2 endoleak after EVAR occurs frequently (39%) and, while not significantly increasing mortality, often leads to aneurysm sac growth requiring secondary interventions.
Type 2 endoleak after EVAR warrants close sac surveillance; leaves open optimal intervention thresholds in prospective studies.
Type 2 endoleak has been proved not to significantly increase the risk of aneurysm rupture. However, it is associated with aneurysm enlargement and may require secondary interventions. Its role has been widely investigated, but a definitive consensus about its management has still not been obtained. We performed a retrospective, single-center observational study that investigates the incidence of type 2 endoleak and its implications in the long-term follow-up in all the patients who underwent endovascular aortic repair (EVAR) for abdominal aortic aneurysm from 2011 to 2016 at our institution. A total of 216 patients who underwent EVAR during the specified time period were enrolled, and 85 of them (39%) developed type 2 endoleak in their follow-up. Thirty-one of the patients who developed type 2 endoleak faced an aneurysm sac growth > 10 mm and required secondary intervention. Only nine of them showed resolution of the leak. In the long-term follow-up, patients who developed type 2 endoleak after EVAR did not show a significantly increased mortality compared with those who did not, but some of them required late open conversion due to aneurysm sac enlargement and some other developed a secondary type 1 endoleak which required correction. The management of type 2 endoleak remains debated, despite consensus exist regarding the need for intervention when a > 10-mm aneurysm sac growth is observed. Further studies are necessary to better define which are the "high-risk" type 2 endoleaks and identify the patients who would benefit more from correction.
No takes yet. Share an insight, caveat, or question.
Compagnoni et al. (2023) conducted an observational in Abdominal aortic aneurysm (n=216). Type 2 endoleak vs. No type 2 endoleak was evaluated on Incidence of type 2 endoleak and long-term mortality. Type 2 endoleak developed in 39% of patients after EVAR and did not significantly increase long-term mortality, though 31 of 85 affected patients required secondary intervention for sac growth.
Synapse has enriched one closely related paper. Consider it for comparative context: